Clinical Trial Update: Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Campath (alemtuzumab) for induction and maintenance therapy in pancreas after kidney transplantation was terminated. The trial relate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• CAMPATH (ALEMTUZUMAB)

Snippet

Sponsor: University of Minnesota | Conditions: Diabetes Mellitus | Phase 4 | Status: TERMINATED